To investigate whether c-MYC was necessary for the WS6-mediated cytotoxicity, we used the P493-6 Burkitt lymphoma cell line, which expresses a doxycycline-repressible c-MYC transgene [23]. This evidence concerns the gene MYC and Burkitt lymphoma.